Non-small cell lung cancer metastatic

• A study to evaluate novel immunotherapy combinations in participants with advanced non-small cell lung cancer (NSCLC) Halted
  2023-508730-34-00 9 2024-07-10 "Non-small cell lung cancer (NSCLC): - Locally advanced NSCLC"
• A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small … Halted
  2023-503298-39-00 5 2024-06-13 "Metastatic Non-Small Cell Lung Cancer (mNSCLC)"
• Study of Repotrectinib and CYP450 probe Cocktail in Patients with locally advanced or Metastatic Tyrosine Kinase Inhibitors (TKI)-Pretreated … Ended
  2024-511030-12-00 3 2025-02-03 "Non-small Cell Lung Cancer (NSCLC)"
• A Phase 1 Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation Ended
  2023-503223-26-00 9 2024-05-07 "Advanced Solid Tumors Harboring a KRASG12C Mutation"
• A PHASE 2 STUDY EVALUATING INCB099280 IN PARTICIPANTS WITH SELECT SOLID TUMORS WHO ARE IMMUNE CHECKPOINT INHIBITOR–NAÏVE Ended
  2022-502716-37-00 4 2023-11-27 "Recurrent or advanced/metastatic solid tumors who are immuno"
• A Phase Ib/II, Multi-Center, Open-Label Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Efficacy of GFH925 in Combination w … Ended
  2022-501451-87-00 9 2023-03-31 "Previously Untreated Advanced NSCLC Harboring KRAS G12C Muta"
• A phase I of TG6050 in the treatment of patients with metastatic lung cancer Ended
  2024-513093-22-00 1 2023-03-27 "Non-small cell lung cancer (NSCLC)"
• The effect of oral folinic acid to prevent pemetrexed induced adverse events. Ended
  2022-502345-10-00 6 2023-02-05 "Non small cell lung cancer (NSCLC), Mesothelioma, Thymoma"
• A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies Ended
  2023-504400-29-00 1 2022-09-15 "Advanced malignancies."
• A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with Pembrolizumab, as First-line Tr … Ended
  2024-511561-10-00 4 2022-05-31 "Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)"
• ​Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination with Chemotherapy Versus Pembrolizumab Plus Chemotherapy as Fir … Ended
  2023-506074-12-00 5 2022-03-22 "Metastatic Non-Small Cell Lung Cancer"
• PET-DOPA Metabolic Detection and Characterization of Untreated Brain Metastases of Bronchial, Breast and Melanoma Cancer Ended
  2024-515850-26-00 4 2021-12-03 "patients with newly discovered brain metastases (non-small c"
• Phase I Clinical Study to Assess Safety and Efficacy of Repotrectinib Combined with Osimertinib in Patients with Advanced, Metastatic EGFR M … Ended
  2023-509776-41-00 3 2021-06-30 "Non-small cell lung cancer (NSCLC)"
• MK-7684A (new drug co-formulation of pembrolizumab with an anti-TIGIT) plus docetaxel works to help stop or slow down the growth of your non … Ended
  2022-501252-28-00 4 2021-04-15 "Non Small Cell Lung cancer"
• A first-in-human clinical trial in adult patients with advanced non-small cell lung cancer of a personalised therapy targeting specific muta … Ended
  2024-513060-26-00 7 2021-04-07 "Non-small cell lung cancer"
• A study to test the efficacy and safety of Lazertinib in the treatment of patients with Locally Advanced or Metastatic Non-Small Cell Lung C … Ended
  2024-514771-18-00 5 2020-12-15 "Adenocarcinoma of the lung (non-small cell lung cancer); loc"
• SAR408701 versus docetaxel in previously treated, carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) positive metastatic no … Ended
  2024-515101-26-00 5 2020-08-21
• A Study of Tiragolumab, an Anti-TIGIT Antibody, in Combination with Atezolizumab Compared with Placebo in Combination with Atezolizumab (an … Ended
  2022-502482-17-00 5 2020-05-19 "Non-small cell lung cancer (NSCLC)"
• A Study to Assess Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small … Ended
  2023-508083-30-00 4 2018-07-19 "Non-small cell lung cancer (NSCLC)"
• A Study to Evaluate Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Metastatic Non-Small Cell Lu … Ended
  2023-504038-23-00 9 2018-05-10 "Metastatic non-small cell lung cancer (NSCLC)"
• A clinical trial to evaluate if CC-486 plus pembrolizumab works and is safe in patients with advanced or metastatic non-small cell lung canc … Ended
  2024-513405-31-00 4 2015-12-10 "Second-line treatment of locally advanced or metastatic non-"
• A trial to show the similarity in effects, safety and immune response of FYB206 compared to Keytruda in people with metastatic non-squamous … Ended
  2023-509766-37-00 5 "NSCLC"
• A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons … Ended
  2024-515393-27-00 4 "Nonsquamous non-small cell lung cancer"
• A Study of Valemetostat Tosylate Plus Pembrolizumab versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations Ended
  2024-519671-26-00 9 "Advanced or Metastatic Non-Small Cell Lung Cancer"

Showing 49–72 of 72 trials